Showing results (91-100 of 279) with videos related to
Sort By:
Pageof 28
Antimicrobial Agents and Chemotherapy|December 1, 1995
In vitro activity of a new pneumocandin antifungal agent, L-733,560 against azole-susceptible and -resistant Candida and Torulopsis speciesJ A Vazquez, M Lynch, J D SobelReviews of Infectious Diseases|March 1, 1989
Liver abscess caused by Streptococcus milleriD Chua, H H Reinhart, J D SobelMycoses|July 1, 2009
Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decadesC C Bulik, J D Sobel, M D NailorReviews of Infectious Diseases|September 1, 1990
Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microfloraV Redondo-Lopez, R L Cook, J D SobelJournal of Medicine|January 1, 1984
Staphylococcus aureus bacteremia and endocarditis: comparison of nosocomial and community-acquired infectionR Finkelstein, J D Sobel, A Nagler, et al.Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|September 1, 1996
Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasisM E Lynch, J D Sobel, P L FidelThe American Journal of Medicine|August 1, 1982
Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contaminationJ D Sobel, N Hashman, G Reinherz, et al.Dermatologica|January 1, 1976
Aspects of lymphocyte function in Behçet's diseaseS Haim, T Mekori, J D Sobel, et al.Infection and Immunity|July 1, 1995
Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasisP L Fidel, M E Lynch, J D SobelClinical Microbiology Reviews|January 9, 1999
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicansP L Fidel, J A Vazquez, J D SobelPageof 28